(YSG) Yatsen Holding - Ratings and Ratios
Cosmetics, Skincare, Tools, Kits, Sunscreen, Devices
YSG EPS (Earnings per Share)
YSG Revenue
Description: YSG Yatsen Holding
Yatsen Holding (NYSE:YSG) is a China‑originated public company operating in the Personal Care Products sub‑industry, with its shares listed as common stock on the New York Stock Exchange.
Core performance metrics that investors track include revenue growth (typically double‑digit YoY in the fast‑growing Chinese beauty segment), gross margin (often in the high‑40% range due to a direct‑to‑consumer model), adjusted EBITDA margin (generally mid‑20% after scaling marketing spend), and free cash flow conversion (aiming for >70% of EBITDA). Inventory turnover is a critical efficiency indicator given the rapid product cycles in cosmetics, with turnover ratios above 5× considered healthy.
Key economic drivers for YSG are Chinese consumer discretionary spending, especially among Gen Z and Millennials, the continued shift toward online and mobile shopping, and the effectiveness of influencer‑driven marketing (KOLs and live‑streaming). Macro‑level factors such as GDP growth, urbanization rates, and disposable income trends directly affect demand for premium personal‑care brands.
Strategic levers include expanding the brand portfolio (e.g., Perfect Diary, Florasis, and other high‑growth labels), deepening omnichannel capabilities, optimizing supply‑chain latency to reduce working‑capital needs, and leveraging data‑analytics to improve customer acquisition cost (CAC) and repeat‑purchase rates. Regulatory exposure—particularly cosmetics registration and cross‑border e‑commerce rules—remains a material risk that can impact product rollout timelines.
Financial health is monitored through leverage ratios (net debt to EBITDA), liquidity (cash runway relative to operating cash burn), and shareholder return metrics such as earnings per share growth and dividend policy (currently none, with a focus on reinvestment). Operational efficiency is further measured by marketing spend as a percentage of revenue (targeting ~30% to sustain growth while preserving margin) and the payback period on CAC (ideally under 12 months).
YSG Stock Overview
| Market Cap in USD | 904m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 2020-11-19 |
YSG Stock Ratings
| Growth Rating | -9.74% |
| Fundamental | 32.9% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 154% |
| Analyst Rating | 4.0 of 5 |
YSG Dividends
Currently no dividends paidYSG Growth Ratios
| Growth Correlation 3m | 23.3% |
| Growth Correlation 12m | 78.7% |
| Growth Correlation 5y | -64.4% |
| CAGR 5y | -38.19% |
| CAGR/Max DD 5y | -0.39 |
| Sharpe Ratio 12m | 0.96 |
| Alpha | 191.21 |
| Beta | 0.384 |
| Volatility | 72.74% |
| Current Volume | 445k |
| Average Volume 20d | 480.1k |
| Stop Loss | 8.6 (-7.9%) |
| Signal | -1.08 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-528.3m TTM) > 0 and > 6% of Revenue (6% = 224.7m TTM) |
| FCFTA -0.07 (>2.0%) and ΔFCFTA -8.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 45.81% (prev 58.79%; Δ -12.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.06 (>3.0%) and CFO -246.7m > Net Income -528.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (92.7m) change vs 12m ago -9.23% (target <= -2.0% for YES) |
| Gross Margin 77.86% (prev 74.83%; Δ 3.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 86.47% (prev 72.69%; Δ 13.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' -13.17
| (A) 0.42 = (Total Current Assets 2.37b - Total Current Liabilities 658.5m) / Total Assets 4.04b |
| (B) -2.00 = Retained Earnings (Balance) -8.08b / Total Assets 4.04b |
| warn (B) unusual magnitude: -2.00 — check mapping/units |
| (C) -0.03 = EBIT TTM -145.2m / Avg Total Assets 4.33b |
| (D) -8.78 = Book Value of Equity -7.94b / Total Liabilities 904.3m |
| Total Rating: -13.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 32.94
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield -5.51% = -2.76 |
| 3. FCF Margin -8.03% = -3.01 |
| 4. Debt/Equity 0.10 = 2.50 |
| 5. Debt/Ebitda -4.98 = -2.50 |
| 6. ROIC - WACC -11.71% = -12.50 |
| 7. RoE -16.45% = -2.50 |
| 8. Rev. Trend 18.45% = 0.92 |
| 9. Rev. CAGR 8.98% = 1.12 |
| 10. EPS Trend 26.75% = 0.67 |
| 11. EPS CAGR 56.40% = 2.50 |
What is the price of YSG shares?
Over the past week, the price has changed by -8.79%, over one month by +4.71%, over three months by +72.01% and over the past year by +197.45%.
Is Yatsen Holding a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of YSG is around 7.81 USD . This means that YSG is currently overvalued and has a potential downside of -16.38%.
Is YSG a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the YSG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.2 | -1.4% |
| Analysts Target Price | 9.2 | -1.4% |
| ValueRay Target Price | 8.6 | -7.6% |
Last update: 2025-08-30 05:04
YSG Fundamental Data Overview
CCE Cash And Equivalents = 1.30b CNY (Cash And Short Term Investments, last quarter)
P/S = 0.2413
P/B = 2.0966
Beta = -2.111
Revenue TTM = 3.75b CNY
EBIT TTM = -145.2m CNY
EBITDA TTM = -59.1m CNY
Long Term Debt = 245.9m CNY (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 48.7m CNY (from shortTermDebt, last quarter)
Debt = 294.6m CNY (Calculated: Short Term 48.7m + Long Term 245.9m)
Net Debt = -774.3m CNY (from netDebt column, last quarter)
Enterprise Value = 5.46b CNY (6.47b + Debt 294.6m - CCE 1.30b)
Interest Coverage Ratio = unknown (Ebit TTM -145.2m / Interest Expense TTM 0.0)
FCF Yield = -5.51% (FCF TTM -300.7m / Enterprise Value 5.46b)
FCF Margin = -8.03% (FCF TTM -300.7m / Revenue TTM 3.75b)
Net Margin = -14.10% (Net Income TTM -528.3m / Revenue TTM 3.75b)
Gross Margin = 77.86% ((Revenue TTM 3.75b - Cost of Revenue TTM 829.5m) / Revenue TTM)
Tobins Q-Ratio = -0.69 (set to none) (Enterprise Value 5.46b / Book Value Of Equity -7.94b)
Interest Expense / Debt = 2.53% (Interest Expense 7.46m / Debt 294.6m)
Taxrate = 21.0% (US default)
NOPAT = -145.2m (EBIT -145.2m, no tax applied on loss)
Current Ratio = 3.61 (Total Current Assets 2.37b / Total Current Liabilities 658.5m)
Debt / Equity = 0.10 (Debt 294.6m / last Quarter total Stockholder Equity 3.09b)
Debt / EBITDA = -4.98 (Net Debt -774.3m / EBITDA -59.1m)
Debt / FCF = -0.98 (Debt 294.6m / FCF TTM -300.7m)
Total Stockholder Equity = 3.21b (last 4 quarters mean)
RoA = -13.07% (Net Income -528.3m, Total Assets 4.04b )
RoE = -16.45% (Net Income TTM -528.3m / Total Stockholder Equity 3.21b)
RoCE = -4.20% (Ebit -145.2m / (Equity 3.21b + L.T.Debt 245.9m))
RoIC = -4.52% (NOPAT -145.2m / Invested Capital 3.21b)
WACC = 7.19% (E(6.47b)/V(6.76b) * Re(7.43%)) + (D(294.6m)/V(6.76b) * Rd(2.53%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -40.0 | Cagr: -7.45%
Discount Rate = 7.43% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -300.7m)
Revenue Correlation: 18.45 | Revenue CAGR: 8.98%
Rev Growth-of-Growth: 17.43
EPS Correlation: 26.75 | EPS CAGR: 56.40%
EPS Growth-of-Growth: 176.0
Additional Sources for YSG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle